Tenet Healthcare (MEX:THC) 5-Year EBITDA Growth Rate: 18.70% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:THC Tenet Healthcare Corp MEX:THC
78 GF Score
Price MXN3,547.50
GF Value MXN2,552.92
! 5 Warning Signs
View Full Analysis

What is Tenet Healthcare 5-Year EBITDA Growth Rate?

Tenet Healthcare MEX:THC 78 5-Year EBITDA Growth Rate is 18.70% as of Jun. 2026. GuruFocus rates MEX:THC with a GF Score™ of 78/100 and a GF Value™ of MXN2,552.92. The stock has 5 warning signs investors should review.

Tenet Healthcare's EBITDA per Share for the three months ended in Jun. 2026 was MXN365.55.

During the past 12 months, Tenet Healthcare's average EBITDA Per Share Growth Rate was 32.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 21.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 18.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Tenet Healthcare was 38.50% per year. The lowest was -50.20% per year. And the median was 8.80% per year.


Tenet Healthcare  (MEX:THC) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Tenet Healthcare 5-Year EBITDA Growth Rate Related Terms


MEX:THC vs DVA, EHC, ENSG: 5-Year EBITDA Growth Rate Comparison

For the Medical Care Facilities subindustry, Tenet Healthcare's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenet Healthcare 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tenet Healthcare's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Tenet Healthcare's 5-Year EBITDA Growth Rate falls into.


MEX:THC
78GF Score
Tenet Healthcare Corp MEX:THC
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tenet Healthcare 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 18.70% mean?
Tenet Healthcare (MEX:THC) has a 5-Year EBITDA Growth Rate of 18.70% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Tenet Healthcare and its competitors.
Is Tenet Healthcare's 5-Year EBITDA Growth Rate too high?
Tenet Healthcare's current 5-Year EBITDA Growth Rate is 18.70%. Overall, Tenet Healthcare has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Tenet Healthcare's 5-Year EBITDA Growth Rate compare to DVA and EHC?
Tenet Healthcare's 5-Year EBITDA Growth Rate of 18.70% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Tenet Healthcare and its competitors. Tenet Healthcare's current 5-Year EBITDA Growth Rate is 18.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenet Healthcare stock overvalued right now?
Tenet Healthcare (MEX:THC) has a current 5-Year EBITDA Growth Rate of 18.70%. The stock's GF Value™ is MXN2,552.92, compared to a current price of MXN3,547.50 — trading 39% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 18.70%. Tenet Healthcare's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Tenet Healthcare (MEX:THC), the current 5-Year EBITDA Growth Rate is 18.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tenet Healthcare (MEX:THC) Overvalued in 2026?

Based on GuruFocus' analysis, Tenet Healthcare stock appears to be overvalued. The current stock price of MXN3,547.50 is trading 39% above its estimated GF Value™ of MXN2,552.92.

Key valuation signals for MEX:THC:

  • 5-Year EBITDA Growth Rate: 18.70%
  • GF Value™: MXN2,552.92 vs. price of MXN3,547.50 (39% above fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the MEX:THC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tenet Healthcare Business Description

Address 14201 Dallas Parkway, Dallas, TX, USA, 75254
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
78GF Score

Get the complete analysis for MEX:THC

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,547.50
Price
MXN2,552.92
GF Value